Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment

Afonso, 2020, Competitive glucose metabolism as a target to boost bladder cancer immunotherapy, Nat Rev Urol, 17, 77, 10.1038/s41585-019-0263-6 Evlampidou, 2020, Trihalomethanes in drinking water and bladder cancer burden in the European Union, Environ Health Perspect, 128, 1, 10.1289/EHP4495 Marks, 2016, Female with bladder cancer: what and why is there a difference?, Transl Androl Urol, 5, 668, 10.21037/tau.2016.03.22 Clocchiatti, 2016, Sexual dimorphism in cancer, Nat Rev Cancer, 16, 330, 10.1038/nrc.2016.30 Cheng, 2016, Gender dimorphism creates divergent cancer susceptibilities, Trends Cancer, 2, 325, 10.1016/j.trecan.2016.06.001 Uhlig, 2018, Gender-specific differences in recurrence of non–muscle-invasive bladder cancer: a systematic review and meta-analysis, Eur Urol Focus, 4, 924, 10.1016/j.euf.2017.08.007 Wang, 2020, Pan-cancer immunogenomic analyses reveal sex disparity in the efficacy of cancer immunotherapy, Eur J Cancer, 126, 136, 10.1016/j.ejca.2019.12.008 Koti, 2019, Investigating the STING pathway to explain mechanisms of BCG failures in non-muscle invasive bladder cancer: prognostic and therapeutic implications, Bladder Cancer, 5, 225, 10.3233/BLC-190228 Kamat, 2018, Predicting response to intravesical bacillus Calmette-Guérin immunotherapy: are we there yet? A systematic review, Eur Urol, 73, 738, 10.1016/j.eururo.2017.10.003 Meng, 2019, Emerging immunotherapy options for bacillus Calmette-Guérin in unresponsive nonmuscle invasive bladder cancer, J Urol, 202, 1111, 10.1097/JU.0000000000000297 Morales, 2016, Mycobacterium phlei cell wall-nucleic acid complex in the treatment of nonmuscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin, Expert Opin Biol Ther, 16, 273, 10.1517/14712598.2016.1134483 Morales, 2017, BCG: a throwback from the stone age of vaccines opened the path for bladder cancer immunotherapy, Can J Urol, 24, 8788 Capone, 2018, Sexual dimorphism of immune responses: a new perspective in cancer immunotherapy, Front Immunol, 9, 552, 10.3389/fimmu.2018.00552 Radkiewicz, 2020, Sex differences in urothelial bladder cancer survival, Clin Genitourin Cancer, 18, 10.1016/j.clgc.2019.10.020 Fernandez-Gomez, 2008, Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials, Eur Urol, 53, 992, 10.1016/j.eururo.2007.10.006 Ingersoll, 2018, Immunology, immunotherapy, and translating basic science into the clinic for bladder cancer, Bladder Cancer, 4, 429, 10.3233/BLC-180175 Kerr, 2017, Discerning predictors for gender differences in survival outcomes for patients treated for bladder cancer, J Clin Oncol, 35, 360, 10.1200/JCO.2017.35.6_suppl.360 Krimphove MJ, Szymaniak J, Marchese M, et al. Sex-specific differences in the quality of treatment of muscle-invasive bladder cancer do not explain the overall survival discrepancy. Eur Urol Focus. 2019;S2405-4569(19)30156-7. Nieder, 2010, Are patients with hematuria appropriately referred to urology? A multi-institutional questionnaire based survey, Urol Oncol, 28, 500, 10.1016/j.urolonc.2008.10.018 Yuan, 2016, Comprehensive characterization of molecular differences in cancer between male and female patients, Cancer Cell, 29, 711, 10.1016/j.ccell.2016.04.001 Kluth, 2013, Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder, World J Urol, 31, 1029, 10.1007/s00345-012-0996-9 D’Andrea, 2020, Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer, Urol Oncol, 38, 639.e1, 10.1016/j.urolonc.2020.01.010 Arnold, 2014, Conceptual frameworks and mouse models for studying sex differences in physiology and disease: why compensation changes the game, Exp Neurol, 259, 2, 10.1016/j.expneurol.2014.01.021 Hsu, 2014, Suppression of ER β signaling via ER β knockout or antagonist protects against bladder cancer development, Carcinogenesis, 35, 651, 10.1093/carcin/bgt348 Hsu, 2014, Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo, Oncotarget, 5, 7917, 10.18632/oncotarget.1421 Ozdemir, 2019, Sex hormones and anticancer immunity, Clin Cancer Res, 25, 4603, 10.1158/1078-0432.CCR-19-0137 Bertram, 1972, Specific induction of bladder cancer in mice by butyl-(4-hydroxybutyl)-nitrosamine and the effects of hormonal modifications on the sex difference in response, Eur J Cancer, 8, 587, 10.1016/0014-2964(72)90137-5 Okajima, 1975, Effects of sex hormones on development of urinary bladder tumours in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine, Urol Res, 3, 73, 10.1007/BF00256185 George, 2013, Chemoprevention of BBN-induced bladder carcinogenesis by the selective estrogen receptor modulator tamoxifen, Transl Oncol, 6, 244, 10.1593/tlo.13247 Mäkelä, 2018, Bladder cancer survival in men receiving 5 a-reductase inhibitors, J Urol, 200, 743, 10.1016/j.juro.2018.04.082 Hsu, 2013, Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor, Am J Pathol, 182, 1811, 10.1016/j.ajpath.2013.01.018 Kashiwagi, 2016, Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract, Cancer Biol Ther, 17, 1188, 10.1080/15384047.2016.1235667 Tukiainen, 2017, Landscape of X chromosome inactivation across human tissues, Nature, 550, 244, 10.1038/nature24265 Schoemaker, 2008, Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study, Lancet Oncol, 9, 239, 10.1016/S1470-2045(08)70033-0 Ji, 2016, Risk of solid tumors and hematological malignancy in persons with Turner and Klinefelter syndromes, Int J Cancer, 139, 754, 10.1002/ijc.30126 Kaneko, 2018, X chromosome protects against bladder cancer in females via a KDM6A-dependent epigenetic mechanism, Sci Adv, 4, eaar5598, 10.1126/sciadv.aar5598 Yap, 2014, Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent mutations of UNC5C and prognostic importance of DNA repair gene mutations on survival, Clin Cancer Res, 20, 6605, 10.1158/1078-0432.CCR-14-0257 Hurst, 2017, Cancer Cell, 32, 10.1016/j.ccell.2017.08.005 Robertson, 2018, Comprehensive molecular characterization of muscle-invasive bladder cancer, Cell, 174, 1033, 10.1016/j.cell.2018.07.036 Pietzak, 2017, Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets, Eur Urol, 72, 952, 10.1016/j.eururo.2017.05.032 Ler, 2017, Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2, Sci Transl Med, 9, eaai8312, 10.1126/scitranslmed.aai8312 Dunford, 2017, Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias, Nat Genet, 49, 10, 10.1038/ng.3726 Jaillon, 2019, Sexual dimorphism in innate immunity, Clin Rev Allergy Immunol, 56, 308, 10.1007/s12016-017-8648-x Webb, 2019, Sex and pubertal differences in the type 1 interferon pathway associate with both X chromosome number and serum sex hormone concentration, Front Immunol, 9, 3167, 10.3389/fimmu.2018.03167 Abelson, 2018, Sex differences in lower urinary tract biology and physiology, Biol Sex Differ, 9, 45, 10.1186/s13293-018-0204-8 Voigt, 2019, Sex differences in older adults’ immune responses to seasonal influenza vaccination, Front Immunol, 10, 180, 10.3389/fimmu.2019.00180 Dai, 2014, Sexual dimorphism of miRNA expression: a new perspective in understanding the sex bias of autoimmune diseases, Ther Clin Risk Manag, 10, 151 vom Steeg, 2016, SeXX matters in infectious disease pathogenesis, PLoS Pathog, 12, e1005374, 10.1371/journal.ppat.1005374 Bongen, 2019, Sex differences in the blood transcriptome identify robust changes in immune cell proportions with aging and influenza infection, Cell Rep, 29, 10.1016/j.celrep.2019.10.019 Piasecka, 2018, Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges, Proc Natl Acad Sci USA, 115, E488, 10.1073/pnas.1714765115 Wang, 2016, Distribution and expression profiles of dendritic cell subpopulations in human bladder cancer, Int J Clin Exp Pathol, 9, 7180 Chevalier, 2017, Immunoregulation of dendritic cell subsets by inhibitory receptors in urothelial cancer, Eur Urol, 71, 854, 10.1016/j.eururo.2016.10.009 Scharff, 2019, Sex differences in IL-17 contribute to chronicity in male versus female urinary tract infection, JCI Insight, 5, e122998, 10.1172/jci.insight.122998 Mora-Bau, 2015, Macrophages subvert adaptive immunity to urinary tract infection, PLoS Pathog, 11, e1005044, 10.1371/journal.ppat.1005044 Conforti, 2018, Cancer immunotherapy efficacy and patients’ sex: a systematic review and meta-analysis, Lancet Oncol, 19, 737, 10.1016/S1470-2045(18)30261-4 Carè, 2018, Sex disparity in cancer: roles of microRNAs and related functional players, Cell Death Differ, 25, 477, 10.1038/s41418-017-0051-x Yang, 2017, Posttranscriptional control of PD-L1 expression by 17β-estradiol via PI3K/Akt signaling pathway in ERα-positive cancer cell lines, Int J Gynecol Cancer, 27, 196, 10.1097/IGC.0000000000000875 Heritz, 1997, Detection of eubacteria in interstitial cystitis by 16S rDNA amplification, J Urol, 158, 2291, 10.1016/S0022-5347(01)68237-5 Keay, 1998, Polymerase chain reaction amplification of bacterial 16S rRNA genes in interstitial cystitis and control patient bladder biopsies, J Urol, 159, 280, 10.1016/S0022-5347(01)64082-5 Siddiqui, 2011, Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons, BMC Microbiol, 11, 244, 10.1186/1471-2180-11-244 Hilt, 2014, Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder, J Clin Microbiol, 52, 871, 10.1128/JCM.02876-13 Fouts, 2012, Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury, J Transl Med, 10, 174, 10.1186/1479-5876-10-174 Lewis, 2013, The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults, Front Cell Infect Microbiol, 3, 41, 10.3389/fcimb.2013.00041 Gottschick, 2017, The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment, Microbiome, 5, 99, 10.1186/s40168-017-0305-3 Markowski, 2019, The microbiome and genitourinary cancer: a collaborative review, Eur Urol, 75, 637, 10.1016/j.eururo.2018.12.043 Bi, 2019, Urinary microbiota—a potential biomarker and therapeutic target for bladder cancer, J Med Microbiol, 68, 1471, 10.1099/jmm.0.001058 Grassadonia, 2018, Effect of gender on the outcome of patients receiving immune checkpoint inhibitors for advanced cancer: a systematic review and meta-analysis of phase III randomized clinical trials, J Clin Med, 7, 542, 10.3390/jcm7120542 Ye, 2020, Sex-associated molecular differences for cancer immunotherapy, Nat Commun, 11, 1779, 10.1038/s41467-020-15679-x Saginala, 2020, Epidemiology of bladder cancer, Med Sci (Basel), 8, 15 Andreassen, 2018, Bladder cancer survival: women better off in the long run, Eur J Cancer, 95, 52, 10.1016/j.ejca.2018.03.001 Wang, 2017, The gender difference and mortality-to-incidence ratio relate to health care disparities in bladder cancer: national estimates from 33 countries, Sci Rep, 7, 4360, 10.1038/s41598-017-04083-z Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2015 Patafio, 2015, Is there a gender effect in bladder cancer? A population-based study of practice and outcomes, Can Urol Assoc J, 9, 269, 10.5489/cuaj.2927 Messer, 2014, Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis, Urology, 83, 863, 10.1016/j.urology.2013.10.060 Otto, 2012, Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder, Gend Med, 9, 481, 10.1016/j.genm.2012.11.001